AntibodyCurated CoreFDAstaleEli LillyApproved
cetuximab (Erbitux)
US label: head and neck squamous cell cancer and biomarker-selected colorectal cancer; regimen-specific indications · EGFR
#EGFR#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 942Status Approved